REFERENCES
- Bluestone CD. Management and therapy of otitis media In: Alberti PW, Ruben RJ (eds): Otologic Medicine and Surgery. New York: Churchill Livingstone, 1988: 1173-201.
- Brook I, Yocum P. Quantitative bacterial cultures and 13-lactamase activity in chronic suppurative otitis media. Ann Otol Rhinol Laryngol 1989; 98: 293–7.
- Kenna MA, Bluestone CD. Microbiology of chronic sup-purative otitis media in children. Pediatr Infect Dis J 1986; 5: 223–5.
- Erkan M, Sevük E, Asian T, Gtitney E. Bacteriology of chronic suppurative otitis media. Ann Otol Rhinol Laryngol 1994; 103: 771–4.
- Mawson S, Ludman H. Diseases of the Ear, 4th ed. London: Edward Arnold Publishers, 1979.
- Altuntas A, Asian A, Ern N et al. Susceptibility of microorganisms isolated from chronic suppurative otitis media to ciprofloxacin. Eur Arch Otorhinolaryngol 1996; 253: 364–6.
- Esposito S, D'Errico G, Montanaro C. Topical and oral treatment of chronic otitis media with ciprofloxacin. A preliminary study. Arch Otolaryngol Head Neck Surg 1990; 116: 557–9.
- Wald ER. Outpatient management of otitis media, mas-toiditis and sinusitis. Semin Pediatr Infect Dis 1990; 1: 383–93.
- National Committee for Laboratory Control Standard Performance Standards for Antimicrobial Susceptibility Testing, vol.15, No. 14, 1995.
- Kenna MA, Bluestone CD, Reilly JS, Lusk RP. Medical management of chronic suppurative otitis media without cholesteatoma. Laryngoscope 1986; 96: 146–51.
- Feigin RD. Pseudomonas infections. In: Feigin RD, Cherry ID (eds): Textbook of Pediatric Infectious Diseases, 3rd ed. Philadelphia: WB Saunders, 1992: 1229-36.
- Ginsberg IA, Rundnick MD, Huber PS. Aminoglycoside ototoxicity following middle ear infection, III: comparative quantitative analysis. Ann Otol Rhinol Laryngol 1980; 89 (suppl.77): 17-24.
- Brownlee RE, Hulka GF, Prazma J, Pillsbury HC. Ciprofloxacin. Use as topical otic preparation. Arch Otolaryngol Head Neck Surg 1992; 118: 392–6.
- Esposito S, Noviello S, D'Errico G, Montanaro C. Topical ciprofloxacin vs intramuscular gentamicin for chronic otitis media. Arch Otolaryngol Head Neck Surg 1992; 118: 842–4.
- Piccirillo JF, Parnes SM. Ciprofloxacin for the treatment of chronic ear disease. Laryngoscope 1989; 99: 510–13.
- Claes J, Govaerts PJ, Van de Heyning PH, Peeters S. Lack of ciprofloxacin ototoxicity after repeated ototopical application. Antimicrob Agents Chemother 1991; 35: 1014–16.
- Schaad UB. Use of quinolones in pediatrics. Drugs 1993; 45 (Suppl. 3): 37-41.
- Chysky V, Kapila K, Hullman R et al. Safety of ciprofloxacin in children: worldwide clinical experience based on compassionate use. Emphasis on joint evaluation. Infection 1991; 19: 289–96.
- Danisovicova A, Brezina M, BeIan S et al. Magnetic resonance imaging in children receiving quinolones: no evidence of quinolone-induced arthropathy. Chemotherapy 1994; 40: 209–14.
- Dagan R, Einhorn M. A program of outpatient parenteral antibiotic therapy for serious pediatric bacterial infections. Rev Infect Dis 1991; 13 (Suppl. 2): S152-S155.
- Einhorn M, Fliss DM, Leiberman A, Dagan R. Otolaryngology and infectious disease team approach for out-patient management of serious pediatric infections requiring parenteral antibiotic therapy Int J Ped Otorhinolar 1992; 24: 245–51.
- Bradley JS. Once daily ceftriaxone in the outpatient treatment of paediatric infections 1991; 37 (Suppl. 3): 3-6.
- Fliss D, Dagan R, Houri Z, Leiberman A. Medical management of chronic suppurative otitis media without cholesteatoma in children. J Pediatr 1990; 116 (6): 991–6.
- Dagan R, Fliss D, Einhorn M, Kraus M, Leiberman A. Outpatient management of chronic suppurative otitis media without cholesteatoma in children. Pediatr Infect Dis J 1992; 11 (7): 542–6.